ABC Arbitrage SA Takes Position in Danaher Corporation $DHR

ABC Arbitrage SA bought a new position in shares of Danaher Corporation (NYSE:DHR) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 11,300 shares of the conglomerate’s stock, valued at approximately $2,142,000.

Other hedge funds have also recently bought and sold shares of the company. Bank Pictet & Cie Europe AG raised its stake in shares of Danaher by 25.4% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock worth $83,895,000 after buying an additional 74,301 shares during the last quarter. Maxi Investments CY Ltd bought a new position in Danaher in the third quarter valued at approximately $3,251,000. Defender Capital LLC. acquired a new stake in Danaher during the 4th quarter worth $35,715,000. Northwestern Mutual Wealth Management Co. raised its position in shares of Danaher by 303.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after acquiring an additional 186,584 shares during the last quarter. Finally, CIBC Bancorp USA Inc. bought a new stake in shares of Danaher during the 3rd quarter valued at $17,480,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have weighed in on DHR. Wall Street Zen lowered Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Argus lowered their price target on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Friday, April 24th. TD Cowen decreased their price objective on shares of Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Barclays cut their target price on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Finally, Royal Bank Of Canada initiated coverage on shares of Danaher in a report on Thursday, May 14th. They issued an “outperform” rating and a $200.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $231.64.

Danaher Stock Performance

NYSE DHR opened at $200.45 on Tuesday. The firm’s fifty day moving average price is $181.02 and its two-hundred day moving average price is $199.06. The firm has a market capitalization of $141.87 billion, a P/E ratio of 38.77, a price-to-earnings-growth ratio of 2.54 and a beta of 0.79. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80.

Danaher (NYSE:DHR) last issued its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period in the previous year, the company posted $1.88 EPS. The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. As a group, research analysts anticipate that Danaher Corporation will post 8.44 EPS for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Friday, June 26th. Danaher’s payout ratio is presently 30.95%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.